DuPont Launches Liveo Pharma TPE Overmolded Assemblies 

DuPont has launched its Liveo Pharma TPE Overmolded Assemblies (OMAs), engineered for ultrapure fluid transfer across upstream and downstream pharmaceutical and biopharmaceutical processes.

Designed as critical components of single‑use systems, the new assemblies help reduce contamination risk, minimize the potential for leakage, and reduce in-house assembly and setup time.

OMAs support the transfer of ultrapure liquids, air or steam while helping manufacturers reduce cleaning, validation and labor requirements associated with traditional single-use systems. The assemblies are engineered for low extractables, strong chemical resistance, and improved heat‑welding performance.

The new TPE assemblies are available in both standard and ultra-low-temperature options designed to meet critical application requirements.

“DuPont Liveo Pharma TPE OMAs are customizable, help reduce the risk of leakage and contamination of ultrapure fluids, and minimize in‑house assembly and setup time and costs,” said Diana Salvadori, DuPont™ Liveo™ Global Senior Product Marketing Manager. “These OMAs are well‑suited for applications such as gene therapies; leak‑free connections; and other high‑value, critical applications, including fill‑and‑finish operations.”